We are live on
!
Find out more
MAM
Meeder Asset Management Portfolio holdings
AUM
$1.75B
1-Year Est. Return
34.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.92%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.33B
AUM Growth
+$172M
(+15%)
Cap. Flow
+$108M
Cap. Flow
% of AUM
8.1%
Top 10 Holdings %
Top 10 Hldgs %
18.38%
Holding
1,833
New
283
Increased
650
Reduced
474
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$15.6M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$12.6M |
| 3 |
Keurig Dr Pepper
KDP
|
+$9.15M |
| 4 |
CSX Corp
CSX
|
+$8.15M |
| 5 |
Humana
HUM
|
+$8.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$17.3M |
| 2 |
Mastercard
MA
|
+$7.29M |
| 3 |
Elevance Health
ELV
|
+$6.89M |
| 4 |
Booking.com
BKNG
|
+$6.27M |
| 5 |
IBM
IBM
|
+$5.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 11.38% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Ligand Pharmaceuticals
LGND
$6.02B
| $51K | ﹤0.01% |
298
+118
| +66% | +$17.8K |
|
777
Madison Square Garden
MSGS
$9.43B
| $51K | ﹤0.01% |
+229
| New | +$50.8K |
|
778
TechTarget
TTGT
$312M
| $51K | ﹤0.01% |
2,632
+50
| +2% | +$1.29K |
|
|
XENT
779
DELISTED
Intersect ENT, Inc
XENT
| $51K | ﹤0.01% |
1,779
-2,208
| -55% | -$66.3K |
|
|
HMSY
780
DELISTED
HMS Holdings Corp.
HMSY
| $51K | ﹤0.01% |
1,530
-1,732
| -53% | -$50.1K |
|
|
ASRT
781
DELISTED
Assertio
ASRT
| $50K | ﹤0.01% |
144
+112
| +350% | +$48.9K |
|
782
Goldgroup Mining Inc.
GORO
$160M
| $50K | ﹤0.01% |
10,077
-1,424
| -12% | -$8.23K |
|
783
Hexcel
HXL
$7.79B
| $50K | ﹤0.01% |
741
-156
| -17% | -$10.6K |
|
784
SoundThinking
SSTI
$101M
| $50K | ﹤0.01% |
+841
| New | +$40.8K |
|
|
TPIC
785
DELISTED
TPI Composites
TPIC
| $50K | ﹤0.01% |
1,759
+715
| +68% | +$20.7K |
|
|
TRTX
786
TPG RE Finance Trust
TRTX
$606M
| $50K | ﹤0.01% |
+2,494
| New | +$50.8K |
|
787
Vanguard Real Estate ETF
VNQ
$38.8B
| $50K | ﹤0.01% |
615
| – | – |
|
|
PVLA
788
Palvella Therapeutics
PVLA
$2.23B
| $50K | ﹤0.01% |
110
-6
| -5% | -$2.61K |
|
|
OSG
789
DELISTED
Overseas Shipholding Group Inc.
OSG
| $50K | ﹤0.01% |
15,751
-648
| -4% | -$2.26K |
|
790
Interface
TILE
$2.04B
| $49K | ﹤0.01% |
2,112
-9
| -0.4% | -$209 |
|
|
NCI
791
DELISTED
Navigant Consulting, Inc.
NCI
| $49K | ﹤0.01% |
2,126
-10,089
| -83% | -$234K |
|
792
BioMarin Pharmaceuticals
BMRN
$11.9B
| $48K | ﹤0.01% |
490
| – | – |
|
|
DX
793
Dynex Capital
DX
$3.18B
| $47K | ﹤0.01% |
2,477
| – | – |
|
|
KG
794
Kestrel Group
KG
$69.7M
| $47K | ﹤0.01% |
828
+822
| +13,700% | +$89.1K |
|
795
PTC Therapeutics
PTCT
$5.91B
| $47K | ﹤0.01% |
979
-3,073
| -76% | -$127K |
|
|
SHYF
796
DELISTED
The Shyft Group
SHYF
| $47K | ﹤0.01% |
3,125
+417
| +15% | +$6.23K |
|
|
CUTR
797
DELISTED
Cutera, Inc.
CUTR
| $47K | ﹤0.01% |
1,420
+58
| +4% | +$2.11K |
|
798
Artisan Partners
APAM
$3.06B
| $46K | ﹤0.01% |
1,434
| – | – |
|
|
CPRX
799
DELISTED
Catalyst Pharmaceutical
CPRX
| $46K | ﹤0.01% |
12,010
-4,502
| -27% | -$14.1K |
|
800
Equity Bancshares
EQBK
$1.05B
| $46K | ﹤0.01% |
1,180
+105
| +10% | +$4.33K |
|
Similar funds
SFI
DF
CIP
PWP
VCM
PAIM
RIA
NM
Meeder Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Meeder Asset Management held 1,833 positions worth $1.33B, up 15% from $1.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Meeder Asset Management deployed $108M of net new capital in Q3 2018, opening 283 new positions and adding to 650 existing holdings. Its largest new stake was Humana: 24,758 shares worth $8.38M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $17.3M trimmed.
- Meeder Asset Management's largest Q3 2018 buy was Humana: 24,758 shares worth $8.38M.
- Meeder Asset Management added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2018, an estimated $15.6M increase.
- Meeder Asset Management's biggest Q3 2018 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $17.3M.
- Meeder Asset Management fully exited Centene in Q3 2018, selling an estimated $3.09M.
- Meeder Asset Management's ten largest holdings make up 18% of its $1.33B portfolio in Q3 2018.
- Meeder Asset Management opened 283 new positions and closed 294 in Q3 2018.
- Meeder Asset Management's portfolio value rose 15% quarter-over-quarter to $1.33B.
Based on Meeder Asset Management's 13F filing for Q3 2018, filed 2 Nov 2018.